Get the Stockscreener App
0.90
0.57%
-0.0052
Pre-market:
.87
-0.03
-3.33%
Revelation Biosciences Inc stock is traded at $0.90, with a volume of 108.78K.
It is down -0.57% in the last 24 hours and down -14.29% over the past month.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
See More
Previous Close:
$0.9052
Open:
$0.93
24h Volume:
108.78K
Relative Volume:
0.93
Market Cap:
$5.33M
Revenue:
-
Net Income/Loss:
$-15.52M
P/E Ratio:
-0.0484
EPS:
-18.58
Net Cash Flow:
$-16.61M
1W Performance:
-1.13%
1M Performance:
-14.29%
6M Performance:
-67.27%
1Y Performance:
-88.05%
1-Day Range:
$0.89
$0.93
1-Week Range:
$0.8762
$0.93
52-Week Range:
$0.702
$8.16
Revelation Biosciences Inc Stock (REVB) Company Profile
Name
Revelation Biosciences Inc
Sector
Industry
Phone
650-800-3717
Address
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
Compare REVB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
REVB
Revelation Biosciences Inc
|
0.90 | 5.36M | 0 | -15.52M | -16.61M | -18.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
449.53 | 115.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
754.14 | 79.76B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
799.33 | 50.16B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
366.86 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.75 | 38.85B | 4.98B | 69.59M | 525.67M | 0.5197 |
Revelation Biosciences Inc Stock (REVB) Latest News
Revelation Bio To Share New Data From PRIME Study Of Gemini In March - Nasdaq
Options Flow: Can Revelation Biosciences Inc beat the S P 500July 2025 Reactions & Accurate Intraday Trade Tips - baoquankhu1.vn
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026) - Sarasota Herald-Tribune
New kidney study to show how Gemini may help acute injury patients - Stock Titan
Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Sarasota Herald-Tribune
Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development - Corning Leader
Aug Opening: What risks investors should watch in Revelation Biosciences Inc Equity Warrant stock - Bộ Nội Vụ
Wall Street Recap: Can Revelation Biosciences Inc beat the S P 500Weekly Trade Review & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
Biotech recruits new employee with 90,000 stock units over 2 years - Stock Titan
Earnings Recap: Will Revelation Biosciences Inc Equity Warrant benefit from green energy policiesEarnings Summary Report & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Why Revelation Biosciences Inc. stock remains resilient2025 Valuation Update & Verified Technical Trade Signals - Улправда
Bond Watch: Why Revelation Biosciences Inc stock is a must watch in 2025Watch List & Technical Entry and Exit Tips - Bộ Nội Vụ
HOKA Recommended Models: Is Revelation Biosciences Inc. Equity Warrant stock a buy for dividend growthDaily Trainer Picks & trail grip notes for mixed terrain - Улправда
How to contact the Daily Bulletin - FinancialContent
How Revelation Biosciences Inc. stock performs after earningsDollar Strength & Entry Point Confirmation Signals - ulpravda.ru
Is Revelation Biosciences Inc. Equity Warrant stock attractive after correctionPortfolio Performance Report & AI Powered Market Entry Strategies - ulpravda.ru
Will Revelation Biosciences Inc. stock benefit from AI adoptionMarket Sentiment Report & Fast Entry Momentum Trade Alerts - ulpravda.ru
Is Revelation Biosciences Inc. Equity Warrant stock ready for breakoutJuly 2025 Weekly Recap & Weekly Top Performers Watchlists - Улправда
Why Revelation Biosciences Inc. stock is a must watch in 2025Trade Risk Assessment & Daily Stock Momentum Reports - Улправда
Why Revelation Biosciences Inc. stock attracts high net worth investorsMarket Risk Report & Momentum Based Trading Signals - Улправда
Is Revelation Biosciences Inc. Equity Warrant stock affected by interest rate hikes2025 Key Highlights & Daily Oversold Stock Bounce Ideas - Улправда
Can Revelation Biosciences Inc. stock deliver sustainable ROESell Signal & Entry Point Confirmation Alerts - ulpravda.ru
How Revelation Biosciences Inc. stock performs during Fed tightening cyclesJuly 2025 Analyst Calls & Expert-Curated Trade Recommendations - Улправда
How Revelation Biosciences Inc. stock trades during market volatilityWeekly Trend Report & AI Based Buy/Sell Signal Reports - ulpravda.ru
Will Revelation Biosciences Inc. Equity Warrant stock reach all time highs in 2025 - Улправда
Revelation Biosciences, Inc.Common Stock (NQ: REVB - FinancialContent
Revelation Biosciences begins GMP manufacturing for GEMINI trials By Investing.com - Investing.com Nigeria
Potential acute kidney injury drug moves toward larger clinical trials - Stock Titan
Upcoming EventsRevelation Biosciences, Inc.Warrant (Nasdaq:REVBW) Stock Quote - FinancialContent
Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025 - Lubbock Avalanche-Journal
Published on: 2026-01-01 23:42:59 - bollywoodhelpline.com
Price Action: How Revelation Biosciences Inc stock performs after earnings2025 Support & Resistance & Reliable Momentum Entry Alerts - Bộ Nội Vụ
Viking Therapeutics (NASDAQ:VKTX) and Revelation Biosciences (NASDAQ:REVB) Head to Head Contrast - Defense World
Marshall Machines Limited (MARSHALL) Expands into New MarketTrading Psychology Tips & Low Risk Capital Growth Plans - bollywoodhelpline.com
Revelation Biosciences, Inc. (NASDAQ:REVB) Short Interest Update - Defense World
Revelation Biosciences on track for end-of-phase 1 meeting later this year - MSN
Revelation Biosciences reaches quorum for Dec. 3 special meeting - MSN
Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year - Reno Gazette Journal
Total debt per share of Revelation Biosciences, Inc. – NASDAQ:REVB - TradingView — Track All Markets
Revelation Biosciences, Inc. (REVB) Raises $4M in Public Offering - MSN
Why Revelation Biosciences Inc. stock is favored by pension fundsChart Signals & Free Expert Approved Momentum Trade Ideas - Улправда
Market Recap: What risks investors should watch in Revelation Biosciences Inc. stockMarket Weekly Review & Scalable Portfolio Growth Methods - Улправда
Aug Summary: Will Revelation Biosciences Inc. stock recover faster than marketGap Up & Verified Swing Trading Watchlist - Улправда
How Revelation Biosciences Inc. stock trades before earningsJuly 2025 Big Picture & Short-Term High Return Strategies - DonanımHaber
Is Revelation Biosciences Inc. stock undervalued vs historical averagesMarket Trend Report & Verified Technical Signals - DonanımHaber
Revelation Biosciences Inc Stock (REVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.44%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):